These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16084279)

  • 1. Percutaneous coronary interventions in the high-risk renal patient: strategies for renal protection and vascular protection.
    McCullough PA; Berman AD
    Cardiol Clin; 2005 Aug; 23(3):299-310. PubMed ID: 16084279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
    Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond serum creatinine: defining the patient with renal insufficiency and why?
    McCullough PA
    Rev Cardiovasc Med; 2003; 4 Suppl 1():S2-6. PubMed ID: 12556731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention.
    McCullough P
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):335-43. PubMed ID: 16489569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.
    Patti G; Nusca A; Chello M; Pasceri V; D'Ambrosio A; Vetrovec GW; Di Sciascio G
    Am J Cardiol; 2008 Feb; 101(3):279-85. PubMed ID: 18237585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
    Cavusoglu E; Chhabra S; Marmur JD; Kini A; Sharma SK
    Minerva Cardioangiol; 2004 Oct; 52(5):419-32. PubMed ID: 15514576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
    Best PJ; Steinhubl SR; Berger PB; Dasgupta A; Brennan DM; Szczech LA; Califf RM; Topol EJ;
    Am Heart J; 2008 Apr; 155(4):687-93. PubMed ID: 18371477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of coronary artery disease in patients with chronic kidney disease.
    Coats WC; Baig SZ; Alpert MA; Aggarwal K
    Adv Perit Dial; 2009; 25():125-8. PubMed ID: 19886333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interventional revascularization for cardiovascular disease in patients with chronic kidney disease].
    Ishii H; Murohara T
    Nihon Rinsho; 2011 Feb; 69(2):339-42. PubMed ID: 21387687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serious renal dysfunction after percutaneous coronary interventions can be predicted.
    Brown JR; DeVries JT; Piper WD; Robb JF; Hearne MJ; Ver Lee PM; Kellet MA; Watkins MW; Ryan TJ; Silver MT; Ross CS; MacKenzie TA; O'Connor GT; Malenka DJ;
    Am Heart J; 2008 Feb; 155(2):260-6. PubMed ID: 18215595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a rapid intra-arterial infusion of dextrose 5% prior to coronary angiography on frequency of contrast-induced nephropathy in high-risk patients.
    Clavijo LC; Pinto TL; Kuchulakanti PK; Torguson R; Chu WW; Satler LF; Kent KM; Suddath WO; Waksman R; Pichard AD
    Am J Cardiol; 2006 Apr; 97(7):981-3. PubMed ID: 16563900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of coronary artery disease in patients with chronic kidney disease.
    Edwards NC; Steeds RP; Ferro CJ; Townend JN
    QJM; 2006 Nov; 99(11):723-36. PubMed ID: 17040978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery disease and peripheral vascular disease in chronic kidney disease: an epidemiological perspective.
    Stack AG
    Cardiol Clin; 2005 Aug; 23(3):285-98. PubMed ID: 16084278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents.
    Shaw JA; Andrianopoulos N; Duffy S; Walton AS; Clark D; Lew R; Sebastian M; New G; Brennan A; Reid C; Ajani AE;
    Cardiovasc Revasc Med; 2008; 9(4):218-23. PubMed ID: 18928945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different types of renal dysfunction in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kowalczyk J; Lenarczyk R; Kowalski O; Sredniawa B; Musialik-Lydka A; Gasior M; Polonski L; Zembala M; Gumprecht J; Kalarus Z
    J Interv Cardiol; 2007 Apr; 20(2):143-52. PubMed ID: 17391223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term clinical outcomes in patients with moderate renal insufficiency undergoing stent based percutaneous coronary intervention.
    Zhang RY; Ni JW; Zhang JS; Hu J; Yang ZK; Zhang Q; Lü AK; Shen WF
    Chin Med J (Engl); 2006 Jul; 119(14):1176-81. PubMed ID: 16863609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention.
    Uddin MA; Rabbani MA; Jafary FH; Bhatti MA; Islam M
    J Coll Physicians Surg Pak; 2005 Dec; 15(12):791-4. PubMed ID: 16398973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk prediction of contrast-induced nephropathy.
    McCullough PA; Adam A; Becker CR; Davidson C; Lameire N; Stacul F; Tumlin J;
    Am J Cardiol; 2006 Sep; 98(6A):27K-36K. PubMed ID: 16949378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure.
    Baber U; Toto RD; de Lemos JA
    Am Heart J; 2007 Apr; 153(4):471-7. PubMed ID: 17383281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical and renal consequences of contrast-induced nephropathy.
    Finn WF
    Nephrol Dial Transplant; 2006 Jun; 21(6):i2-10. PubMed ID: 16723349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.